EFFECT OF INTRAVESICAL PROSTATIC PROTRUSION (IVPP) ON LOWER URINARY TRACT FUNCTION AND MANAGEMENT

Similar documents
= 0.62, P <0.001) with important clinical exceptions. There was negative correlation between the PV and Qmax (r s

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Hee Young Park, Joo Yong Lee, Sung Yul Park, Seung Wook Lee, Yong Tae Kim, Hong Yong Choi, Hong Sang Moon

Bladder outlet obstruction number- a good indicator of infravesical obstruction in patients with benign prostatic enlargement?

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Can men with prostates sized 80 ml or larger be managed conservatively?

Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?

CHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89

Objective: to determine the correlation of intravesical prostatic protrusion

Lasers in Urology. Sae Woong Choi, Yong Sun Choi, Woong Jin Bae, Su Jin Kim, Hyuk Jin Cho, Sung Hoo Hong, Ji Youl Lee, Tae Kon Hwang, Sae Woong Kim

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate

INJINTERNATIONAL. Efficacy of Holmium Laser Enucleation of the Prostate Based on Patient Preoperative Characteristics. Original Article INTRODUCTION

ISSN: (Print) (Online) Journal homepage:

Impact of urethral catheterization on uroflow during pressure-flow study

Naoki Wada, Seiji Matsumoto, Masafumi Kita, Kazumi Hashizume and Hidehiro Kakizaki

Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction

Can 80 W KTP Laser Vaporization Effectively Relieve the Obstruction in Benign Prostatic Hyperplasia?: A Nonrandomized Trial

Lasers in Urology. Myung Soo Kim, Kyung Kgi Park 1, Byung Ha Chung, Seung Hwan Lee.

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

What should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee

Elderly Men with Luts: The Role of Urodynamics

URODYNAMICS IN MALE LUTS: NECESSARY OR WASTE OF TIME?

THE ACONTRACTILE BLADDER - FACT OR FICTION?

Novel Natural Fill Telemetric Pressure Flow Study of Discomfort and Bladder Outlet Obstruction

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

The ICS- BPH Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction

Original Article INJ Purpose: Methods: Results: Conclusions: Keywords: INTRODUCTION Corresponding author:

Urodynamics and Benign Prostatic Hyperplasia

Hakmin Lee, Minsoo Choo, Myong Kim, Sung Yong Cho, Seung Bae Lee, Hyeon Jeong, Hwancheoul Son

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

Clinical Study Treatment Strategy According to Findings on Pressure-Flow Study for Women with Decreased Urinary Flow Rate

Management of LUTS after TURP and MIT

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Office Management of Benign Prostatic Enlargement

Strong Impact of Nocturia on Sleep Quality in Patients with Lower Urinary Tract Symptoms

Diagnosis and Mangement of Nocturia in Adults

An Anteriorly Positioned Midline Prostatic Cyst Resulting in Lower Urinary Tract Symptoms

Tzu Chi Medical Journal

European Urology 44 (2003) 89 93

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

THE EVOLUTION OF DETRUSOR OVERACTIVITY AFTER WATCHFUL WAITING, MEDICAL THERAPY AND SURGERY IN PATIENTS WITH BLADDER OUTLET OBSTRUCTION

EAU GUIDELINES POCKET EDITION 3

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

Lower urinary tract symptoms (LUTS) are common, affecting approximately

Management of LUTS. Simon Woodhams February 2012

University of Bristol - Explore Bristol Research

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms

Noninvasive Methods to Evaluate Bladder Obstruction in Men

Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia

Does uroflowmetry parameter facilitate discrimination between detrusor underactivity and bladder outlet obstruction?

INJ. Noninvasive Urodynamic Evaluation. Review Article INTRODUCTION

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

Department of Urology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea 4

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study

The Enlarged Prostate Symptoms, Diagnosis and Treatment

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

Managing urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester

Assistant Professor, Department of General Surgery, NEIGRIHMS, Shillong, Meghalaya, India

Original Article - Lasers in Urology. Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, Youn Soo Jeon

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Chapter 4: Research and Future Directions

BPH: a present and future perspective on health impact

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

New Treatment Modalities for Benign Prostatic Hyperplasia. Seung-June Oh, MD Department of Urology, Seoul National University Hospital

A Comparative Study of Trans Urethral Resection Versus Trans Urethral Incision for Small Size Obstructing Prostate

Association of BPH with OAB: The Plumbing or the Pump?

LUTS after TURP: How come and how to manage? Matthias Oelke

Transurethral incision versus transurethral resection of the prostate in small prostatic adenoma: Long-term follow-up

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Effect of Voiding Position on Uroflowmetric Parameters in Healthy and Obstructed Male Patients

The UroCuff Test. A non-invasive pressure-flow diagnostic for male LUTS patients. Summary of supporting evidence

Overactive Bladder Syndrome

PROSPERO International prospective register of systematic reviews

Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

Male LUTS. Dr. Brian Ho. Division of Urology Department of Surgery Queen Mary Hospital

Ferdinando Fusco * , Massimiliano Creta, Nicola Longo, Francesco Persico, Marco Franco and Vincenzo Mirone

The Journal of International Medical Research 2012; 40:

Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey

Management of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

Influence of body mass index on Benign Prostatic Hyperplasia-related complications in patients undergoing prostatectomy

TURP: How Much Should Be Resected? International Braz J Urol Vol. 35 (6): , November - December, 2009 doi: /S

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

Benign prostatic hyperplasia (BPH) is one of the

INVESTIGATION OF LOWER URINARY TRACT SYMPTOMS IN UROLOGICAL OUTPATIENTS USING ORIGINAL IPSS PLUS POST MICTURITION DRIBBLE QUESTIONNAIRE

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

PAE Articles Executive Summaries

Transcription:

EFFECT OF INTRAVESICAL PROSTATIC PROTRUSION (IVPP) ON LOWER URINARY TRACT FUNCTION AND MANAGEMENT Rajaraman T 1, Balaji A. R 2, Vetrichandar S 3, Shekar M. G 4, Bhat K. R. S 5, Muthurathinam R 6, Ashokkumar R 7, Lakshminarayan K. R 8 1Professor & HOD, Department of Urology, Government Stanley Hospital, Chennai. 2Associate Professor, Department of Urology, Government Stanley Hospital, Chennai. 3Assistant Professor, Department of Urology, Government Stanley Hospital, Chennai. 4Assistant Professor, Department of Urology, Government Stanley Hospital, Chennai. 5Junior Resident, Department of Urology, Government Stanley Hospital, Chennai. 6Junior Resident, Department of Urology, Government Stanley Hospital, Chennai. 7Junior Resident, Department of Urology, Government Stanley Hospital, Chennai. 8Junior Resident, Department of Urology, Government Stanley Hospital, Chennai. ABSTRACT AIMS AND OBJECTIVES To correlate Intravesical Prostatic Protrusion (IVPP) with International Prostate Symptoms Score (IPSS), Quality of Life Index (QOL), Uroflowmetry, Post Void Urine (PVR) and Pressure Flow Study (PFS) and to assess whether the presence and increasing grades of Intravesical prostatic protrusion are directly correlated with the severity of Bladder outlet obstruction due to Benign prostatic hypertrophy. MATERIALS AND METHODS Non-randomized prospective cohort study, conducted in Department of Urology, Govt. Stanley Hospital, from June 2012 to June 2015, on a sample of 100 patients with IVPP. IVPP was correlated with IPSS, Quality of life index, Uroflowmetry, Effects of drug therapy, Response to surgical therapy. Response of patients with Intravesical prostatic protrusion of same grade to surgical therapy and drug therapy are compared to decide which modality of management is best. RESULTS The incidence of IVPP in patients presenting with LUTS due to BPH is 1 in 5. Majority present with grade 2 IVPP. The increasing grades of IVPP are significantly directly correlated with IPSS score, Q-max and Post void residual. Statistical analysis showed IVPP to correlate significantly with BOO. TURP showed a very good and significant mean decrease of IPSS and Q-max, whereas those who had medical treatment showed only a mean decrease of 2 in IPSS score and 1 in Q-max. CONCLUSION The increasing grades of IVPP are significantly directly correlated with IPSS score max and Post void residual. IVPP have a very good positive and negative predictive value and also a good accuracy rate in comparison with all other parameters in predicting the BOO. The surgical intervention statistically proved to be superior to medical treatment in IVPP patients. KEYWORDS IVPP, Prostate, Urology. HOW TO CITE THIS ARTICLE: Rajaraman T, Balaji AR, Vetrichandar S, et al. Effect of intravesical prostatic protrusion (IVPP) on lower urinary tract function and management. J. Evolution Med. Dent. Sci. 2016;5(55):3796-3800, DOI: 10.14260/jemds/2016/869 INTRODUCTION Intravesical Prostatic Protrusion (IVPP) is represented as a severe parameter of the Bladder Outlet Obstruction (BOO) due to Benign Prostatic Hypertrophy (BPH) traditionally and it is considered based on the experience that it can be cured only by surgical management. But till date it is not made standard in various association guidelines and in standard textbooks except for a few publications in literature. In symptomatic benign prostatic hypertrophy patients, there is no consensus or clear practical guidelines to define the presence and severity of obstruction, other than the pressure-flow study. The latter has been traditionally regarded as the reference Financial or Other, Competing Interest: None. Submission 31-03-2016, Peer Review 27-04-2016, Acceptance 03-05-2016, Published 11-07-2016. Corresponding Author: Dr. Balaji A. R, Department of Urology, NSB 6 th Floor, Government Stanley Hospital, Chennai-1. E-mail: balaji_ur@yahoo.co.in DOI: 10.14260/jemds/2016/869 gold standard, but the technique is invasive, uncomfortable for the patient, time-consuming and expensive and not available, especially in most developing countries. The intravesical prostatic protrusion may not be present in all cases of benign prostatic hypertrophy and hence cannot be accomplished as a single non-invasive measure for assessing the severity of Bladder outlet obstruction due to Benign prostatic hypertrophy. But whomsoever is having Intravesical prostatic protrusion may be considered to be suffering from severe Bladder outlet obstruction and may be taken up for surgical intervention rather than observing with medical management. 1 AIM OF THE STUDY To correlate Intravesical Prostatic Protrusion (IVPP) with International Prostate Symptoms Score (IPSS), Quality of Life Index (QOL), Uroflowmetry. 2, Post Void Urine (PVR) and Pressure Flow Study (PFS) and to assess whether the presence and increasing grades of Intravesical prostatic protrusion are directly correlated with the severity of Bladder outlet obstruction due to Benign prostatic hypertrophy. J. Evolution Med. Dent. Sci./eISSN- 2278-4802, pissn- 2278-4748/ Vol. 5/ Issue 55/ July 11, 2016 Page 3796

Response of patients with Intravesical prostatic protrusion of same grade to surgical therapy and drug therapy are compared to decide which modality of management is best. MATERIALS AND METHODS 1. Prospective study. 2. Period of study is from June 2012 to June 2015. 3. Age range 50 to 80 years. 4. The sample size is 100. 5. The patients with comorbid illness such as Diabetes Mellitus (DM), Hypertension (HTN), Tuberculosis (TB), etc. and associated neurological conditions are excluded from the study. Patients with a known history of previous lower urinary tract surgery, prostate or bladder carcinoma, bladder calculi or neurological deficit are also excluded from the study. Intravesical Prostatic Protrusion (IVPP) is Correlated with: 1. International Prostate Symptoms Score (IPSS). 2. Quality of Life Index (QOL). 3. Uroflowmetry. 4. Pressure Flow Study (PFS). 5. Effects of surgical therapy. 6. Response to drug therapy. The initial evaluation consisted of the International Prostate Symptoms Score (IPSS) and Quality-Of-Life (QUOL) score, a physical examination including a DRE to exclude tumour and a neurological examination to exclude any neurological deficit and neurologically related bladder dysfunction. The bladder is next assessed by Transabdominal Ultrasonography (TAUS). A grading system is used with three grades depending on the degree of IPP by measuring the vertical distance from the tip of the protrusion to the circumference of the bladder at the base of the prostate gland. 3 Intravesical prostatic protrusion (IVPP) is graded into three with Transabdominal Ultrasound (TAUS). 4 with the bladder volume of 150-200 ml. Grade I < 5 mm. Grade II - 5 to 10 mm. Grade III >10 mm. After the Transabdominal Ultrasound (TAUS). 5,6 assessment, the peak urinary flow rate (Q max) and voided volume are measured using Uroflowmetry and the Post Void Residual urine volume (PVR) is measured by diagnostic ultrasonography of the bladder either using the double mode in ultrasound or using the formula L*B*H*0.0523 considering the spherical shape. Prostate volume is measured by diagnostic ultrasonography of the bladder either using the double mode in ultrasound or using the formula L*B*H*0.0523 considering the spherical shape. Urine analysis and culture are done. Patients with positive cultures are treated with appropriate antibiotics and rendered culture free before proceeding with the protocol. Renal Function test is done and patients with renal insufficiency are excluded. PSA was also measured and those who had higher values are excluded from the study. Cystoscopy is done routinely in all patients even though not indicated in all patients according to the standard guidelines after getting the consent. The cases enrolled in the study after this period underwent routinely the Pressure Flow study using the Delphi s TM Laborie urodynamic machine. BOO was defined by the BOO index (detrusor pressure at Qmax (2* Qmax)) and then correlated with the clinical variables including age, IPSS 7,8, QoL, Qmax, PVR, prostatic volume and IPP grade; the sensitivities and specificities of these variables were then calculated. Logistic regression and Pearson correlation were used for the statistical analysis and correlation coefficient was calculated for the significance. The Intravesical prostatic protrusion is correlated with the severity of Bladder outlet obstruction due to BPH as assessed by symptoms score, QOL index, Uroflowmetry, cystoscopy and confirmed with Pressure Flow study. Those patients who are fit and willing for surgery and those patients indicated for surgery are proceeded with conventional TURP. Other patients are put under drug treatment - a combination of Tamsulosin and Dutasteride for a period of 3 months. The patients who failed medical treatment are planned to undergo surgery after a period of 2 weeks and are observed whether they succeed in voiding or not. This is a non-randomized prospective cohort study compared on the respective grades and the treatment is said to be effective and complete when Uroflowmetry Peak flow >15 ml/sec, IPSS mild or no symptoms, QOL improvement by >- 2 grades and IVPP absent or grade I. RESULTS 1. The Incidence of Intravesical prostatic protrusion presented to our department in those who presented with Lower urinary tract symptoms due to benign prostatic hyperplasia is around 1: 5. (100:516). 2. Mean Age - 64 (100 men). 3. Total symptoms distribution J. Evolution Med. Dent. Sci./eISSN- 2278-4802, pissn- 2278-4748/ Vol. 5/ Issue 55/ July 11, 2016 Page 3797

4. Intravesical prostatic protrusion Grade. Grade Number I 28 II 43 III 29 5. IVPP and Correlation (all 100 patients). 9,10 6. AUR and IVPP: 34 patients had acute urinary retention with Intravesical prostatic protrusion due to Benign prostatic hypertrophy (34%); 85% of AUR pts. had IVPP >5 mm. 7. Cystoscopy. Lobes Enlarged % Lateral lobes 12 Median lobe 31 Both 57 8. Around 61 out of 100 underwent urodynamic evaluation (61%). 9. Analysis of parameters. 10. Treatment. IVPP Medical Rx TURP Grade I 12 16 Grade II 11 32 Grade III 5 24 11. Comparing the medical and surgical treatment (12 cases of grade I put under medical Rx compared with 12 cases of grade I underwent TURP. Similarly, 11 cases of grade II and 5 cases of grade III are compared). Grade I Grade II IPSS Mean decrease by 2 5 PF Mean increase 1 3 QOL Mean decrease 0 0 Coefficient _0.121 0.351 P value <0.231 <0.034 IPSS Mean decrease by 2 7 PF Mean increase 1 4 QOL Mean decrease 0 1 Coefficient _0.211 0.381 P value <0.311 <0.022 Grade III IPSS Mean decrease by 2 9 PF Mean increase 1 5 QOL Mean decrease 0 1 Coefficient _0.241 0.421 P value <0.351 <0.014 12. AUR and IVPP. IVPP AUR Pts. No. Medical Rx TURP Grade I 5 2 3 Grade II 11 1 10 Grade III 18 1 17 One pt. of Grade I IVPP voided well with medical treatment with follow-up period of 9 months. Other patients of AUR (of all grades IVPP) put under medical treatment failed trial voiding and later proceeded with TURP and succeeded trial voiding. All these patients had PFS and detrusor instability is ruled out in all cases. DISCUSSION The Incidence of Intravesical prostatic protrusion presented to our department in those who presented with Lower urinary tract symptoms due to benign prostatic hyperplasia is around 1:5 (100:516). The mean age is 64 (100 men). Majority of the patients are in the age group between 55 and 70 years; 52% of the patients presented with both obstructive and storage symptoms and the percentage of patients who presented only with obstructive symptoms is 32%. Majority of the patients are in Grade II IVPP (43%), whereas the incidence of Grade I and Grade II patients is almost the same. All the Grades of IVPP are correlated with IPPS score, QOL index max, PVR and Prostatic volume and the significance is calculated using linear regression analysis and Pearson correlation coefficient. The increasing grades of IVPP are significantly directly correlated with IPSS score (r 0.163, p <0.037), Q-max (r 0.231 p<0.027) and Post-void residual (r 0.331 p<0.031). 11 Among the three Q-max is the best correlated one. The Prostatic volume (p<0.131) and QOL index (p<0.053) do not correlate well with IVPP. 12 The percentage of the patients who presented with acute urinary retention is 34%. Cystoscopy is done in all patients and majority of them had enlargement of both lateral and median lobes (57%). Median lobe alone is presented as IVPP in 31% and lateral lobe alone is in 12%. Majority of the grade II and III IVPP in TAUS showed trilobar prostatic enlargement in cystoscopy. 13 Urodynamics are done according to the good urodynamic practices recommended by the International Continence Society. Bladder Outlet Obstruction Index (BOOI), defined as the Detrusor s pressure at the maximum urinary flow (Pdet_Q-max) minus two times the maximum flow (Q-max): BOOI=pdet_qmax-2 x Qmax. Values below 20 were considered non-obstructed, between 20 and 40 inconclusive and higher than 40, obstructed. But we have classified the values into two in this study whether obstructed or not obstructed, i.e. above 40 is obstructed and below 40 is not obstructed. Pressure flow study is done only in 61 patients (out of 100), as the Urodynamic machine (Delphi s TM Laborie) is available only from mid-2013 in our department; 71% of grade I, 78% of grade II and 88% of grade III IVPP had significant obstruction (BOOI >40) demonstrated with pressure flow study (p<0.011). 14 The equivocal criteria in PF study (BOOI 20-40) is not considered in this study and BOOI >40 are considered as obstructed, whereas BOOI <40 are considered as non-obstructed. IPPS score (with the criteria >21 as significant), Q-max (with the criteria >10 ml/sec as significant) and PVR (with the criteria >50 ml as significant) J. Evolution Med. Dent. Sci./eISSN- 2278-4802, pissn- 2278-4748/ Vol. 5/ Issue 55/ July 11, 2016 Page 3798

are significantly and directly correlated with the obstruction as demonstrated by the Pressure flow study. 15 (P<0.041, p<0.031 and p<0.041 respectively), whereas the Prostatic volume and QOL index comparatively have lesser significance in assessing the obstruction. 16,17 (P<0.142 and p<0.167 respectively). Those patients presented with AUR after the period of mid-2013, made their catheter removed and proceeded with pressure flow study. With the urodynamic catheter in situ, they proceeded with voiding study and they voided minimally even though they did not void in the previously conducted Uroflowmetry machine. Based on their significant criteria for obstruction as mentioned above and 2*2 table mode statistical analysis, Q- max, PVR and IPSS have good positive predictive values (PPV 72, 68 and 58 respectively) for assessing the severity of obstruction as confirmed by Pressure flow study. 7,8 Among the three Q-max alone have a good negative predictive value (NPV 69), whereas others have similar NPV (around 44). IVPP along with Q-max and PVR is correlated for obstruction as demonstrated by PFS and analysed statistically using computer software packages SPSS (Statistical Package for Social Sciences) and Positive predictive value calculator 9.0. IVPP has a very good positive and negative predictive values (78, 73) and also a good accuracy rate (78) in comparison with all other parameters in predicting the BOO. 14 This is especially very significant in increasing grades of protrusion. In conclusion from this prospective analysis the IVPP correlates significantly with BOO; it should be used as one of the variables initially assessed in men with LUTS, being a less invasive (than pressure-flow studies in every patient) and a more costeffective way to stratify patients with LUTS for further management. On the treatment aspect, those patients who are fit and willing for surgery and those patients indicated for surgery are proceeded with conventional TURP. Others are put under medical treatment. This comparison comes under Grade B recommendation of evidence, as this is level II evidence. Statistical and graphical analysis was performed using computer software packages SPSS (Statistical Package for Social Sciences) 12.0 for Windows and Microsoft Excel. No patient underwent open prostatectomy, as no one had prostatic volume greater than 75 cc. Comparing the medical and surgical treatment (12 cases of grade I put under medical Rx compared with 12 cases of grade I underwent TURP. Similarly, 11 cases of grade II and 5 cases of grade III are compared). TURP showed a very good and significant mean decrease of IPSS and Q-max (p<0.014 to 0.034; r 0.351 to 0.421), whereas those who had medical treatment showed only a mean decrease of 2 in IPSS score and 1 in Q-max (p<0.231 to 0.351; r _0.241 to _0.121) in all grades irrespectively. The patients who showed improvement in IPSS score with medical treatment had storage symptoms, especially before the treatment. There is no decrease in the measurement of IVPP in those patients with medical treatment, whereas TURP patients showed no demonstrable protrusion. The QOL index decreased by mean 1 in those underwent TURP, whereas the mean decrease is zero in those who had medical treatment. One pt. of Grade I IVPP voided well with medical treatment with follow-up period of 9 months. Other patients of AUR (of all grades IVPP) put under medical treatment failed trial voiding and later proceeded with TURP and succeeded trial voiding. All these patients had PFS and detrusor instability is ruled out in all cases. So surgical intervention statistically proved to be superior to medical treatment in IVPP patients, especially most significant in Grade II and III IVPP patients. CONCLUSION 1. The increasing grades of IVPP are significantly directly correlated with IPSS score max and post void residual. Among the three, Q-max is the best correlated one. The Prostatic volume and QOL index do not correlate well with IVPP. 18 2. IVPP has a very good positive and negative predictive value and also a good accuracy rate in comparison with all other parameters in predicting the BOO. This is especially very significant in increasing grades of protrusion. Thus, the IVPP correlates significantly with BOO. 19 ; it should be used as one of the variables initially assessed in men with LUTS being less invasive (than pressure-flow studies in every patient. 20 ) and a more cost-effective way to stratify patients with LUTS for further management. 3. The surgical intervention statistically proved to be superior to medical treatment in IVPP patients, especially most significant in Grade II and III IVPP patients. 4. In patients presented with AUR along with IVPP surgery proved the efficacy for successful trial voiding. The patients failed medical treatment, voided successfully after TURP. REFERENCES 1. Chia SJ, Heng CT, Chan SP, et al. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 2003;91(4):371-4. 2. Schäfer W, Abrams P, Liao L, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressureflow studies. Neurourol Urodyn 2002;21(3):261-74. 3. Franco G, Denunzio C, Leonardo C, et al. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness-new standards for non-invasive bladder outlet obstruction diagnosis? J Urol 2010;183(6):2270-4. 4. Kang M, Kim M, Choo MS, et al. Urodynamic features and significant predictors of bladder outlet obstruction in patients with lower urinary tract symptoms/benign prostatic hyperplasia and small prostate volume. Urology 2016;89:96-102. 5. Dicuio M, Pomara G, Vesely S, et al. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch ital urol andrl 2005;77(1):50-3. 6. Yuen JS, Ngiap JT, Cheng CW, et al. Effects of bladder volume on transabdominal ultrasound measurements of Intravesical prostatic protrusion and volume. Int J Urol 2002;9(4):225-9. 7. Netto NR, D'Ancona CA, DeLima ML. Correlation between the international prostatic symptom score and a pressureflow study in the evaluation of symptomatic benign prostatic hyperplasia. J Urol 1996;155(1):200-2. 8. ElDin KE, Kiemeney LA, De Wildt MJ, et al. The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score. J Urol 1996;156(3):1020-5. J. Evolution Med. Dent. Sci./eISSN- 2278-4802, pissn- 2278-4748/ Vol. 5/ Issue 55/ July 11, 2016 Page 3799

9. Din EK, Kiemeney LA, DeWildt MJ, et al. Correlation between uroflowmetry, prostate volume, post void residue, and lower urinary tract symptoms as measured by the international prostate symptom score. Urology 1996;48(3):393-7. 10. Tan YH, Foo KT. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol 2003;170(6 Pt 1):2339-41. 11. Keqin Z, Zhishun X, Jing Z, et al. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology 2007;70(6):1096-9. 12. Lim KB, Ho H, Foo KT, et al. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol 2006;13(12):1509-13. 13. Bantis A, Zissimopoulos A, Kalaytzis C, et al. Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia. Hell J Nucl Med 2007;10(2):138-43. 14. Nose H, Foo KT, Lim KB, et al. Accuracy of two non-invasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology 2005;65 (3): 493-7. 15. Jepsen JV, Bruskewitz RC. Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 1998;51(4A Suppl):13-8. 16. Steele GS, Sullivan MP, Sleep DJ, et al. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol 2000;164(2):344-8. 17. Grossfeld GD, Coakley FV. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging. Radiol Clin North Am 2000;38(1):31-47. 18. Mastrigt RV, Pel JJM. Towards a non-invasive urodynamic diagnosis of intravesical obstruction. BJU Int 1999;84:195-203. 19. Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology 1999;54(1):90-6. 20. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurement and from residual urine. Br J Urol 1979;51(2):129-34. J. Evolution Med. Dent. Sci./eISSN- 2278-4802, pissn- 2278-4748/ Vol. 5/ Issue 55/ July 11, 2016 Page 3800